A trial of oral immunotherapy in children and adolescents highly allergic to peanut, treated with AR101 resulted in higher doses of peanut protein that could be ingested without dose-limiting symptoms according to research published yesterday. To see the RTE news clip featuring an Irish participant and commentary from Professor Hourihane, Paediatric Allergist at Cork University Hospital […]